Clinical Trials on Perfusion Index and Pleth Variability Index an Early Indicator of the Success of Brachial Plexus Blo in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- InflaRx GmbH
- Equipe MiMes
- Maria Lendorf
- Bjørgene Omsorgssenter, Haugesund
- Reina Sofia University Hospital
- Neuregenix
- North Karelia Hospital District
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Centro di Procreazione Assistita Demetra
- AIDS Council of New South Wales
- Bruce County Paramedic Service
- BayCare Health System
- Veeda Oncology
- Chengdu Nuoen Biotechnologies, Inc.
- Grand Challenges Canada
- ImproveCareNow (ICN)
- Prestige Biopharma Limited
- Nestor Soler Porcar, MD, PhD
- Mononuclear Therapeutics Ltd.
- Women and children's hospital of Jiaxing university
- View Full List
Medical Conditions
- Chlamydophila Infections
- Painless Hysteroscopy
- Spine Surgeries
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Childhood Langerhans Cell Histiocytosis
- Skull Base Neoplasms
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Predictors of Atrial Fibrillation Recurrences
- Fetus or Neonate Affected by External Version Before Labor
- Closure; Foramen Ovale
- Epidemic Hemorrhagic Fever
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Tay-Sachs Disease Ganglioside
- Gullian Barre Syndrome
- Pulmonary Adenocarcinoma
- Multisystem Proteinopathy
- Fracture Dislocation of Cervical Spine
- Endocarditis Infective
- Psoriasis, Arthritic
- Ewing's Family Tumors
- View Full List
Drug Interventions
- Cereport
- Vehicle
- Neihulizumab
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Redifferentiation with retinoid acid
- Adriamycin
- Qingkailing injection 40 ml
- Esomeprazole 40mg before
- Adapalene Gel 0.3%
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- High dose pantoprazole infusion
- Semapimod
- EFV +TVA
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Chemotherapeutic Agent
- Palliative care group first-line scheme
- Azelastine hydrochloride (BAYR9258)
- Estradiol+Drospirenone
- Glimepiride
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Egypt
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Latvia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Peru
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Thailand
- Contract Research Organizations in Türkiye
- Contract Research Organizations in United States
- Contract Research Organizations in Zimbabwe
- CRO list by country